Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Whittier Trust Co. cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,239 shares of the biopharmaceutical company’s stock after selling 634 shares during the quarter. Whittier Trust Co.’s […]
Shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $86.06, but opened at $83.90. Gilead Sciences shares last traded at $84.15, with a volume of 1,252,219 shares trading hands. Wall Street Analyst Weigh In A number of research analysts have […]
ING Groep NV trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 38.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 474,121 shares of the biopharmaceutical company’s stock after selling 300,791 shares during […]
Parcion Private Wealth LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,701 shares of the biopharmaceutical company’s stock, valued at approximately $202,000. Several other institutional investors have […]
Park Avenue Securities LLC grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,326 shares of the biopharmaceutical company’s stock after purchasing an additional 5,436 shares during the period. Park Avenue […]